Results 41 to 50 of about 52,364 (182)

New opportunities in the allergic rhinitis therapy

open access: yesМедицинский совет, 2021
Allergic rhinitis (AR) is one of the most common allergic diseases, especially in economically developed countries, including Russia. The main goal of AR therapy is the control achievement over the disease symptoms, the minimizing of the future ...
K. S. Pavlova, D. S. Mdinaradze
doaj   +1 more source

Effects of orally administered olopatadine hydrochloride on the ocular allergic reaction in rats [PDF]

open access: yes, 2003
BackgroundOlopatadine hydrochloride is an antiallergic agent with histamine H1 receptor antagonistic action. We investigated the effects of olopatadine on passive anaphylaxis reaction- and compound 48/80-induced conjunctivitis in rats.MethodsAllergic ...
Tamura, Tadafumi   +11 more
core   +1 more source

UV-Spectrophotometric Estimation of Olopatadine hydrochloride in Bulk and Pharmaceutical Dosage Form by Zero, First and Second Order Derivative Methods [PDF]

open access: yes, 2019
Simple and accurate UV spectrophotometric methods by Zero, First and Second order derivative method  have been developed and validated for the estimation of Olopatadine hydrochloride in bulk and its pharmaceutical dosage form.
Saudagar, Ravindranath B.   +2 more
core   +1 more source

Dupilumab treatment of a case of asthma, chronic rhinosinusitis, and atopic dermatitis after initial benralizumab administration

open access: yesJournal of Cutaneous Immunology and Allergy, Volume 3, Issue 4, Page 91-93, August 2020., 2020
The present paper reports a patient with asthma, chronic rhinosinusitis, and atopic dermatitis treated by dupilumab after initial benralizumab administration. Benralizumab was moderately effective on asthma but not for chronic rhinosinusitis and atopic dermatitis.
Haruna Matsuda‐Hirose   +4 more
wiley   +1 more source

Comparison of two ophthalmic solutions of olopatadine hydrochloride (0.1%) and epinastine hydrochloride (0.05%) on clinical signs of vernal keratoconjunctivitis and side effects of the two drugs [PDF]

open access: yes, 2020
Background: Vernal keratoconjunctivitis (VKC) is a recurrent, bilateral, external, ocular inflammation primarily affecting young adults living in warm dry climates. The objectives of the research was to compare the two ophthalmic solutions of olopatadine
Ansari, Tahir Husain, Rizvi, Yusuf
core   +1 more source

Effects of Neuropeptides In The Development Of The Atopic Dermatitis Of Mouse Models

open access: yesAllergology International, 2004
Background: Neuropeptides are considered to be factors that trigger, exacerbate or modulate allergic diseases and inflammatory skin reactions. In addition, it has been indicated that allergic diseases are highly correlated with stress.
Masako Kojima   +5 more
doaj   +1 more source

Prophylactic Treatment with Olopatadine Hydrochloride for Cedar Pollenosis

open access: yesPractica Oto-Rhino-Laryngologica, 2004
Effectiveness and safety of olopatadine hydrochloride were studied in 30 patients with cedar pollenosis by administering the agent before and after cedar pollen began to disperse. After receiving a pre-scription for olopatadine hydrochloride 5mg twice a day, patients recorded nasal symptoms, any hindrance in daily activities, itching of the eye and ...
Hayashi, Shuichiro   +7 more
openaire   +2 more sources

Combined intranasal treatment for allergic rhinitis: an option for children under 12 years of age [PDF]

open access: yesExploration of Asthma & Allergy
Intranasal treatments combining corticosteroids with antihistamines are a safe and effective alternative for treating moderate to severe seasonal allergic rhinitis in children over 12 years of age and adults.
Alberto Vidal, Pedro Cortez
doaj   +1 more source

PHARMACOKINETIC STUDY OF OLOPATADINE 10 MG EXTENDED RELEASE TABLET IN COMPARISON WITH OLOPATADINE 5 MG IMMEDIATE RELEASE TABLET IN INDIAN POPULATION [PDF]

open access: yes, 2021
Objective: This study was designed to assess the pharmacokinetics of single dose of olopatadine hydrochloride 10 mg extended release (ER) tablet of Ranbaxy laboratories limited (two test formulations) with two doses of Allelock® 5 mg immediate release ...
MARWAH, AMIT   +3 more
core   +1 more source

Comparison of the efficacy between olopatadine hydrochloride and desloratadine citrate disodium for chronic urticaria

open access: yesPifu-xingbing zhenliaoxue zazhi
Objective To compare the efficacy of olopatadine hydrochloride and desloratadine citrate disodium for the treatment of chronic urticaria. Methods A total of 184 patients with chronic urticaria were enrolled at the department of dermatology of Kaifeng ...
WU Dandan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy